NYSEAMERICAN:MNI - McClatchy Stock Price, Forecast & News

McClatchy trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MNI."

McClatchy Co (NYSEAMERICAN:MNI) announced its quarterly earnings results on Wednesday, November, 13th. The company reported ($0.16) EPS for the quarter, beating the Zacks' consensus estimate of ($1.54) by $1.38. The firm earned $167.44 million during the quarter. View McClatchy's Earnings History.

McClatchy is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for McClatchy.

1 equities research analysts have issued twelve-month price targets for McClatchy's shares. Their forecasts range from $3.00 to $3.00. On average, they expect McClatchy's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 152.1% from the stock's current price. View Analyst Price Targets for McClatchy.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McClatchy in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for McClatchy.

News articles about MNI stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. McClatchy earned a coverage optimism score of -3.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for McClatchy.

McClatchy saw a increase in short interest in December. As of December 13th, there was short interest totalling 210,400 shares, an increase of 45.6% from the November 28th total of 144,500 shares. Based on an average trading volume of 109,800 shares, the short-interest ratio is presently 1.9 days. Currently, 4.8% of the shares of the stock are short sold. View McClatchy's Current Options Chain.

Some companies that are related to McClatchy include Thomson Reuters (TRI), Morningstar (MORN), New York Times (NYT), JOHN WILEY & SONS -CL A (JW.A), Shutterstock (SSTK), Meredith (MDP), E. W. Scripps (SSP), Scholastic (SCHL), Daily Journal (DJCO) and Value Line (VALU).

Based on aggregate information from My MarketBeat watchlists, some companies that other McClatchy investors own include Sarepta Therapeutics (SRPT), NovaBay Pharmaceuticals (NBY), Sangamo Therapeutics (SGMO), Gannett (GCI), Abeona Therapeutics (ABEO), Arbutus Biopharma (ABUS), Achieve Life Sciences (ACHV), AcelRx Pharmaceuticals (ACRX), Adamis Pharmaceuticals (ADMP) and Aldeyra Therapeutics (ALDX).

Shares of MNI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MNI stock can currently be purchased for approximately $1.19.

McClatchy has a market capitalization of $9.44 million. McClatchy employs 3,300 workers across the globe.View Additional Information About McClatchy.

The official website for McClatchy is http://www.mcclatchy.com/.

McClatchy's mailing address is 2100 Q St, SACRAMENTO, CA 95816-6816, United States. The company can be reached via phone at +1-916-3211846.